Scotiabank lowered the firm’s price target on Albemarle (ALB) to $75 from $85 and keeps a Sector Perform rating on the shares. The mid-term market balance for lithium suggests oversupply will continue, leading the firm to see no reason why prices should change meaningfully this year, the analyst tells investors. The firm does see, however, elevated risk of a capital raise mid-term.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
- Albemarle price target lowered to $68 from $73 at Morgan Stanley
- Albemarle price target lowered to $85 from $105 at Deutsche Bank
- Albemarle price target lowered to $103 from $110 at BofA
- Albemarle price target lowered to $123 from $170 at Oppenheimer
- Albemarle price target lowered to $77 from $92 at Baird
